Company Quick10K Filing
Arcadia Biosciences
Price0.26 EPS-3
Shares9 P/E-0
MCap2 P/FCF-0
Net Debt-20 EBIT-23
TEV-18 TEV/EBIT1
TTM 2019-09-30, in MM, except price, ratios
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-03-31
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-25
S-1 2019-12-11 Public Filing
10-Q 2019-09-30 Filed 2019-11-06
S-1 2019-07-26 Public Filing
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-04-01
S-1 2018-12-27 Public Filing
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-20
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-08
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-08
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-06-25
8-K 2020-11-12
8-K 2020-11-12
8-K 2020-08-13
8-K 2020-07-06
8-K 2020-07-06
8-K 2020-06-26
8-K 2020-06-01
8-K 2020-05-14
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-04-16
8-K 2020-03-25
8-K 2019-11-06
8-K 2019-09-27
8-K 2019-09-11
8-K 2019-09-05
8-K 2019-08-22
8-K 2019-08-14
8-K 2019-08-05
8-K 2019-06-12
8-K 2019-06-03
8-K 2019-05-20
8-K 2019-05-08
8-K 2019-03-27
8-K 2019-02-28
8-K 2019-02-13
8-K 2018-11-07
8-K 2018-08-08
8-K 2018-07-31
8-K 2018-06-11
8-K 2018-06-06
8-K 2018-05-12
8-K 2018-05-09
8-K 2018-05-07
8-K 2018-05-02
8-K 2018-03-20
8-K 2018-03-19
8-K 2018-01-19

RKDA 10Q Quarterly Report

Arcadia Biosciences Earnings 2021-03-31

Balance SheetIncome StatementCash Flow
854913-23-59-952013201520172020
Assets, Equity
4.50.6-3.3-7.2-11.1-15.02013201520172020
Rev, G Profit, Net Income
7553319-13-352013201520172020
Ops, Inv, Fin